Corient Private Wealth’s DexCom DXCM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $10.7M | Buy |
122,436
+1,745
| +1% | +$152K | 0.01% | 557 |
|
|
2025
Q1 | $8.24M | Sell |
120,691
-6,688
| -5% | -$457K | 0.01% | 555 |
|
|
2024
Q4 | $9.91M | Sell |
127,379
-2,402
| -2% | -$187K | 0.02% | 517 |
|
|
2024
Q3 | $8.7M | Sell |
129,781
-20,530
| -14% | -$1.38M | 0.01% | 580 |
|
|
2024
Q2 | $17M | Buy |
150,311
+3,403
| +2% | +$386K | 0.03% | 418 |
|
|
2024
Q1 | $20.4M | Sell |
146,908
-16,205
| -10% | -$2.25M | 0.04% | 386 |
|
|
2023
Q4 | $20.2M | Buy |
163,113
+13,132
| +9% | +$1.63M | 0.04% | 384 |
|
|
2023
Q3 | $14.4M | Sell |
149,981
-4,909
| -3% | -$471K | 0.03% | 413 |
|
|
2023
Q2 | $19.9M | Buy |
154,890
+4,844
| +3% | +$623K | 0.05% | 341 |
|
|
2023
Q1 | $17.4M | Buy |
150,046
+4,550
| +3% | +$529K | 0.05% | 341 |
|
|
2022
Q4 | $16.5M | Buy |
+145,496
| New | +$16.5M | 0.06% | 294 |
|